GW Pharmaceuticals plc (GWPH) - NASDAQ
  • wilkinson99 | Send Message 21 Jun

    Premarket Top % Gainers: $IMNP 75%, $NVCN 18%, $DUST 8%, $BXE 8% $OPK $JDST $GBIM $LBTYK $TRX $GBT $BCS $RBS $PUK $AV $SVXY $GWPH $MBT $SAN
      • StockConsultant | Send Message 20 Jun

        Best stocks at support with trade quality, watch $AA $CF $CSLT $FDC $GPRE $GWPH $HLX $HPQ $PEIX $PHH $RYAM $SEMG $SF $YNDX
          • Colin Macleod | Send Message 18 Jun

            $GWPH Technical Analysis Video 6/17/2016
              • TheChartGuys | Send Message 17 Jun

                $GWPH Technical Analysis Video 6/17/2016 #stocks #stocktrading
                  • wilkinson99 | Send Message 3 Jun

                    Premarket Top % Gainers: $AVH 27%, $URG 19%, $TLN 16%, $VMEM 11%, $EBIO 9%, $AMBA 8%, $AVGO 7%, $OGXI $NSAM $TCON $WTI $GWPH $TASR $ARIA
                      • Michael Bryant | Send Message 28 May

                        "GW Pharma ($GWPH) could be closest cannabinoid player to U.S. drug approval." I think Phase 3 will go well.
                          • FortSumter | Send Message 26 May

                            $GWPH Bought a starter position @ $90.71. Everyone needs a little weed in their portfolio.
                            Reply (1)
                            • FortSumter | Send Message 3 Jun
                              : Sold at 93.06. Can't seem to hold uptrend.
                              • Societe Financiers | Send Message 25 May

                                This Marijuana Stock Takes a Step Forward: $GWPH
                                  • mr.investor | Send Message 25 May

                                    $GWPH - Go home! You're drunk!
                                      • Alan Brochstein, CFA | Send Message 5 May

                                        GW Pharma’s Disappointing News From Its Conference Call That Nobody Noticed $GWPH
                                          Company Description
                                          GW Pharmaceuticals Plc engages in the business of discovering, developing and commercializing novel therapeutics from proprietary cannabinoid product platform in a broad range of disease areas. The company operates through the following segments: Commercial, Sativex Research & Development and... More
                                          Sector: Healthcare
                                          Industry: Drug Manufacturers - Other
                                          Country: United Kingdom